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Abstract
Background: Innervation of the clavicle is complex and debated, with scarce data on the analgesic and clinical
impact of regional anaesthesia after surgical repair of clavicle fracture.
Methods: In order to assess the analgesic efficiency of an interscalene brachial plexus block (ISB) for surgical repair
of clavicle fracture, 50 consecutive patients scheduled for surgical fixation of middle/lateral clavicle fracture under
general anaesthesia with ISB were prospectively enrolled. This cohort was compared to a historical control of 76
retrospective patients without regional block. The primary outcome was total intravenous morphine equivalent
consumption at 2 postoperative hours. To assess the ISB impact, both an overall cohort analysis and a case-
matched analysis with each ISB-treated patient matched to a Non-ISB-treated patient was performed. Matching
employed a 1-to-1, nearest-neighbour approach using the Mahalanobis metric.
Results: In the overall cohort, patients with ISB had significantly lower i.v. morphine equivalent consumption at 2
postoperative hours (0.7mg (95% CI 0.1 to 1.2) versus controls 8.8mg (95% CI 7.1 to 10.4); P< 0.0001). These results
persisted after case-matching the cohorts (mean difference for the primary outcome: 8.3mg (95% CI 6.5 to 10.0); P< 0.001).
Conclusions: ISB provides effective analgesia after surgical fixation of middle and lateral clavicle fracture. These results should
help physicians in establishing an analgesic strategy for this type of surgery. Further research is needed to identify the
optimal regional technique for medial third clavicle fractures and the clinically relevant contributions of the cervical and
brachial plexus.
Trial registration: Clinicaltrials.gov – NCT02565342, October 1st 2015.
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Background
Surgical fixation of clavicular fractures may result in
moderate to severe postoperative pain that does not al-
ways respond well to opioid therapy. If effective, a re-
gional technique may therefore represent an analgesic
improvement with the potential to reduce postoperative
opioid consumption [1–3]. However, innervation of the
clavicle remains a source of much debate. A recent re-
port illustrated the state of current anatomic knowledge
on this topic suggesting that contributions might come
from: the cervical plexus through the supraclavicular
nerve or from the brachial plexus with contributions
from the subclavian nerve, the long thoracic nerve or
the suprascapular nerve [4]. This anatomic uncertainty
means anaesthetists struggle to determine the optimal
analgesic strategy [4–6]. Furthermore, to date there has
been no study that evaluates the analgesic efficacy of an
interscalene brachial plexus block in patients with
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clavicular fractures. With the goal to resolve this clinical
dilemma, we undertook a matched case-control cohort
study assessing the analgesic impact of ultrasound-
guided interscalene brachial plexus block (US-ISB) for
patients scheduled for open reduction and internal fix-
ation (ORIF) of middle or lateral clavicle fracture.
Methods
We followed the recommended process described in the
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement [7].
Recruitment
After approval by the Lausanne University Hospital Ethics
Committee (Commission d’Ethique Romande, protocol
number CHUV 317/15, Chairperson Prof. André Panna-
tier) on 26th October 2015, this study was prospectively
registered on clinicaltrials.gov (NCT02565342). All pa-
tients aged 18 to 70 years, American Society of Anesthesi-
ologists score (ASA) I-II, scheduled for middle or lateral
clavicle fracture ORIF at the Lausanne University Hospital
were eligible to participate in this study. Exclusion criteria
included existing neurological deficit in the upper limb,
history of neck surgery or radiotherapy, moderate to se-
vere pulmonary disease, contraindications to peripheral
nerve block (e.g., allergy to local anaesthetics, coagulopa-
thy, infection in the area), pre-existing opioid treatment,
any distracting pain (i.e. polytraumatized patients), preg-
nancy and cognitive or psychiatric condition that might
affect patient assessment. All surgeries were performed
electively. Written informed consent was obtained prior
to the day of surgery.
Ultrasound-guided interscalene brachial plexus block
All US-ISB were performed prior to surgery in a dedi-
cated block procedure room, following an extrafascial
approach without nerve stimulation [8–10]. These
blocks were administered or directly supervised by one
of the authors (EA) who had no further involvement in
the study protocol. Patients were positioned supine with
the head turned 45 degrees to the non-operative side.
Electrocardiogram, pulse oximetry, and blood pressure
monitors were routinely applied, and supplemental oxy-
gen was provided. Peripheral intravenous (i.v.) access
was established and midazolam 1 to 4mg i.v. was ad-
ministered for anxiolysis and sedation as needed. The
needle insertion site was sterilized with a solution of
chlorhexidine 2% in isopropyl alcohol 70%. Under sterile
conditions, a high-frequency linear array transducer
(18–6MHz, HF Linear Array 8870, BK Ultrasound, Pea-
body, Massachusetts) was placed over the interscalene
region to visualize the carotid artery and brachial plexus
in the short axis view. The C5, C6, and C7 roots were
identified as described by Martinoli and colleagues [11].
After skin infiltration with 1 to 3 mL of lidocaine 1%, a
22-gauge 50-mm insulated block needle (SonoPlex Stim
cannula, Pajunk®, Geisingen, Germany) was inserted in-
plane with the US beam on the lateral side of the trans-
ducer. The needle was then advanced under direct US
guidance through the middle scalene muscle and toward
the lateral border of the brachial plexus sheath. The bra-
chial plexus sheath was identified as the linear hypere-
choic layer surrounding the roots of the brachial plexus.
The final needle tip was positioned extrafascially, about
3 to 5 mm laterally to the brachial plexus sheath, at a
depth equidistant between C5 and C6 roots. All patients
received 20mL of bupivacaine 0.5% with epinephrine 1:
200,000 through the block needle without repositioning,
except in cases of reported paraesthesia.
Intraoperative and postoperative procedure
After application of routine monitors in the operating the-
atre, patients received a standard general anaesthetic. Anaes-
thesia was induced using Sufentanil 0.1 to 0.2 μg kg− 1 i.v.
and Propofol 2 to 4mg kg− 1 i.v. with endotracheal intubation
facilitated by rocuronium 0.6mg kg− 1 i.v. Maintenance of an-
aesthesia was via inhaled sevoflurane 1.6 to 2.4% in a 40:60
mixture of oxygen and air. Positive pressure ventilation was
initiated with tidal volume and rate adjusted to maintain an
end-tidal PCO2 of 35 to 40mmHg. Sufentanil 2.5–5.0 μg i.v.
was administered as needed to treat increases in blood pres-
sure or heart rate of more than 15% above pre-induction
baseline values. Muscle relaxation was antagonized with neo-
stigmine 50 μg kg− 1 and glycopyrrolate 5 to 10 μg kg− 1 at the
end of surgery. In the Post-Anesthesia Care Unit (PACU),
pain (numeric rating scale [NRS] ≥ 4 or patient request for
analgesia) was treated with i.v. morphine 1–2mg every 10
min as needed for 2 h following our institutional procedure.
Once oral intake was initiated, patients received oral acet-
aminophen 1000mg every 6 h and oxycodone 5mg every 4
h as needed. Antiemetic medications on the ward included
ondansetron 4mg i.v. and metoclopramide 10mg i.v. as
needed.
Block assessment and definition of successful block
Assessment of sensory and motor blocks was performed by a
research assistant every 5min after local anaesthetic injec-
tion, for a total duration of 30min. Sensory block was tested
in the C5 and C6 dermatomes using a blunt tip needle pin-
prick test (0, no perception; 1, decreased sensation; 2, normal
sensation). Motor block was tested using arm abduction
(C5), and forearm flexion (C6) (inability to overcome gravity,
0; reduced force compared to contralateral arm, 1; no loss of
force, 2). A successful block was defined as complete sensory
(score, 0) and motor (score, 0) block in the distribution of
the C5 and C6 nerve roots within 30min of performing the
US-ISB block.
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Outcomes
The primary outcome was total i.v. morphine consump-
tion at 2 postoperative hours upon departure from the
PACU. Secondary outcomes were intraoperative Sufenta-
nil administration; i.v. morphine equivalent consumption
at 24 postoperative hours; pain scores at rest (NRS 0–10)
at 2 and 24 postoperative hours; and rate of postoperative
nausea and vomiting (PONV) within 24 postoperative
hours. Opioids were converted into equianalgesic doses of
i.v. morphine for analysis (i.v. morphine 10mg = oral oxy-
codone 20mg) [3, 12].
Control cohort selection
All patients aged 18 to 70 years old, ASA score I-II, who
had undergone middle or lateral clavicle fracture ORIF
under general anaesthesia only, between September 2012
and August 2015 at the same institution as this study
was conducted, were included in the historical control
cohort. Exclusion criteria included pre-existing opioid
tolerance, any distracting pain (i.e. polytraumatized pa-
tients), pregnancy and cognitive or psychiatric condition
that might affect patient pain assessment. All surgeries
were performed electively. The data was collected using
the surgical calendar software in use at our institution.
Statistical analysis and matching procedure
Categorical variables are presented as frequencies and con-
tinuous variables are summarized as mean values with 95%
confidence intervals (95% CI). In the preliminary analysis,
ISB-treated and Non-ISB-treated patients were compared
using the Student’s t test or Mann–Whitney U test for con-
tinuous variables, and the Fisher’s exact test or Pearson Chi-
square test for categorical variables, as appropriate. To assess
the impact of the US-ISB procedure on the outcomes, we
matched each ISB-treated patient with a Non-ISB-treated pa-
tient and computed the difference in means. The matching
procedure was 1-to-1 nearest-neighbour matching using the
Mahalanobis metric [13]. Therefore, for each exposed (ISB)
individual, one unexposed (Non-ISB) individual, having the
smallest possible Mahalanobis distance between the two vec-
tors of covariates, (patients’ and intervention characteristics),
was selected, and reversely for each non-exposed individual.
Patients characteristics considered for the matching proced-
ure were the gender, the age, the body mass index, the ASA
score, the fracture location, the total dose of Propofol at in-
duction and the duration of surgery. The standardized mean
differences were computed for each variable before and after
matching to assess the performance of the matching proced-
ure (i.e. balance checking). We also used a logistic regression
approach to assess whether some variables (gender, age, body
mass index, ASA score, fracture location) were associated
with the allocation of US-ISB. Significance was considered at
P < 0.05 based on a two-tailed probability. Statistical analyses
were performed using the Stata 15 statistical package (Stata
Corporation, College Station, Texas, U.S.A.).
Results
Fifty patients with an US-ISB were prospectively included
and compared with 76 patients who did not receive an inter-
scalene brachial plexus block. All US-ISBs attempted were
successful. Table 1 presents patients’ characteristics.
Primary outcome
Before matching, patients who received the US-ISB had
a significantly lower i.v. morphine equivalent consump-
tion at 2 postoperative hours (0.7 mg (CI 95% 0.1 to
1.2)) compared to control patients (8.8 mg (CI 95% 7.1
to 10.4); P < 0.0001; Fig. 1). After matching, the mean
difference was 8.3 mg (95% CI 6.5 to 10.0), which
remained significant (P < 0.001). The logistic regression
analysis results indicated that none of the patients’ char-
acteristics were associated with US-ISB group allocation,
suggesting equivalent cohort selection for both the con-
trol and intervention groups (Additional file 1).
Secondary outcomes
Tables 2 and 3 shows the secondary outcomes before and
after the matching procedure respectively. All secondary






Gender (male / female) 82% / 18% 84% / 16% 0.73
Age (years) 35 (32–38) 36 (32–41) 0.66
Height (cm) 177 (175–179) 177 (174–180) 0.94
Weight (kg) 74 (71–76) 75 (71–78) 0.67
Body Mass Index (kg.m− 2) 23.4 (22.7–24.1) 23.6 (22.8–24.4) 0.67
ASA (I / II) 53% / 47% 50% / 50% 0.77
Fracture location (middle / distal) 78% / 22% 72% / 28% 0.47
Total dose of Propofol at induction (mg) 249 (231–267) 265 (242–287) 0.29
Duration of surgery (minutes) 96 (89–104) 101 (94–108) 0.35
ASA American Society of Anaesthesiologists
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outcomes were significantly lower in the US-ISB group, be-
fore and after the matching procedure, except resting pain
scores and rate of PONV at 24 postoperative hours. Patients
who received the US-ISB consumed significantly less Sufen-
tanil intraoperatively with a mean difference of 28 μg (24-
33 μg, P < 0.001). This also translated into lower pain scores
for the US-ISB group in the PACU with a mean difference of
1.7 (0.8–2.5, P < 0.001) and lower morphine equivalent con-
sumption at 24 h. Although the rate of PONV at 24 h did
not retain a significant difference after the matching pro-
cedure, it is noteworthy to mention that 17% of patients
who did not receive the US-ISB reported an episode of
PONV at 24 h compared to 4% of patients who received
the US-ISB. Balance checking results are provided in the
Additional file 2.
Discussion
This matched case-control cohort study investigated the an-
algesic efficacy of US-ISB for patients undergoing middle or
lateral clavicle fracture ORIF. Our analyses showed that,
when compared with patients who did not receive the
regional procedure, patients with US-ISB received less in-
traoperative Sufentanil, consumed less opioid in i.v. mor-
phine equivalents at 2 and 24 postoperative hours, and
reported lower resting pain scores at 2 postoperative
hours.
As summarized by Tran and colleagues, the clavicle
may be innervated either by the supraclavicular nerve
with its origin from the cervical plexus, or by the long
thoracic nerve, the suprascapular nerve or even the sub-
clavian nerve derived from the brachial plexus; a com-
bined innervation from both plexuses is also possible [4].
We believe that our study brings clinically relevant evi-
dence to this anatomic dilemma and, given the analgesic
impact of US-ISB on postoperative analgesia after clav-
icle fracture ORIF, points towards a clavicle innervated
at least in part by branches from the brachial plexus.
The contribution of the cervical plexus remains unclear
and further studies comparing analgesia provided with
an ISB or a superficial cervical plexus block, or a detailed
cadaveric study, may help to clarify remaining anatomic
uncertainty.
Fig. 1 I.v. morphine consumption equivalents at 2 postoperative hours (mg). Data are expressed as the median with 25th and 75th percentiles
(box), along with upper adjacent and lower adjacent values (whiskers)






Perioperative Sufentanil administration (μg) 45 (42–49) 17 (15–18) < 0.001
Pain scores at rest at 2 postoperative hours (NRS, 0–10) 2.2 (1.8–2.6) 0.6 (0.2–1.1) < 0.001
I.v. morphine equivalent consumption at 24 postoperative hours (mg) 16.7 (14.6–18.7) 6.9 (5.1–8.8) < 0.001
Pain scores at rest at 24 postoperative hours (NRS, 0–10) 2.0 (1.5–2.4) 2.5 (1.9–3.1) 0.12
Rate of PONV within 24 postoperative hours 17% 4% 0.02
NRS numeric rating scale, PONV postoperative nausea and vomiting
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Limitations
Our study contains several limitations. First, this matched
case-control cohort study suffers from the inherent weak-
nesses and potential biases of non-randomized interventions.
Despite the inclusion of a detailed matching procedure, there
may remain unknown confounding factors that might con-
tribute to overestimation of the US-ISB’s analgesic efficacy
during surgical fixation of middle or lateral clavicle fractures.
We believe the likelihood of this is minimal given that our lo-
gistic regression analysis suggested equivalent allocation of
patients across the two cohorts. Second, it could be argued
that local anaesthetic may have spread from the interscalene
groove towards the superficial cervical plexus, thereby limit-
ing interpretation of our results. However, the US-ISB tech-
nique we adopted with an extrafascial needle tip location
minimizes or eliminates the risk of spread towards the super-
ficial cervical block, as recently demonstrated [8–10]. Finally,
further exploration of the medial clavicle is needed given the
middle/lateral distribution of fracture in this cohort.
Conclusions
In conclusion, patients who received an US-ISB benefited
from better analgesia after middle or lateral clavicle fracture
ORIF, when compared with patients without US-ISB, and
these results should help physicians establish an adequate an-
algesic strategy for managing this type of surgery. Further re-
search is needed to identify the optimal regional technique
for medial third clavicle fractures and the clinically relevant
contributions of the cervical and brachial plexus.
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